Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

Vertebral hemangiomas in the thoracic spine of multiple sclerosis patients are connected with fewer demyelinating lesions at the same level. Possible impact on pathophysiology and clinical course.
Loss of Schwann cell plasticity in chronic inflammatory demyelinating polyneuropathy (CIDP).
Nuclear Receptor NR1H3 in Familial Multiple Sclerosis.
Cerebellar contribution to motor and cognitive performance in multiple sclerosis: An MRI sub-regional volumetric analysis.
Complement-independent retinal pathology produced by intravitreal injection of neuromyelitis optica immunoglobulin G.
Partial MHC class II constructs as novel immunomodulatory therapy for stroke.
Retinal imaging and axonal degeneration in later onset multiple sclerosis.
IL-12/IL-23p40 Is Highly Expressed in Secondary Lymphoid Organs and the CNS during All Stages of EAE, but Its Deletion Does Not Affect Disease Perpetuation.
Autophagy Is Involved in the Sevoflurane Anesthesia-Induced Cognitive Dysfunction of Aged Rats.
Alteration of the cytokine signature by various TLR ligands in different T cell populations in MOG37-50 and MOG35-55-induced EAE in C57BL/6 mice.
Progressive Multiple Sclerosis.
Neutrophils and viral-induced neurologic disease.
New insights into the pharmacokinetics and pharmacodynamics of natalizumab treatment for patients with multiple sclerosis, obtained from clinical and in vitro studies.
Re: The effect of venous anatomy on the morphology of multiple sclerosis lesions: a susceptibility-weighted imaging study.
Safety and effectiveness assessment of intravenous immunoglobulin in the treatment of relapsing-remitting multiple sclerosis: A meta-analysis.
Gut microbiome analysis in neuromyelitis optica reveals over-abundance of Clostridium perfringens.
Treatment of ongoing autoimmune encephalomyelitis with activated B-cell progenitors maturing into regulatory B cells.
MicroRNAs associated with the pathogenesis of multiple sclerosis.
The Dress: Transforming a web viral event into a scientific survey.
Postreading Self-Assessment and CME Test-Preferred Responses.
Laquinimod decreases Bax expression and reduces caspase-6 activation in neurons.
Programmed cell death and natural killer cells in multiple sclerosis: new potential therapeutic targets?
Case Report: GcMAF Treatment in a Patient with Multiple Sclerosis.
Neuromuscular Determinants For Walking Performance In Individuals With Multiple Sclerosis: 2570 Board #93 June 3, 9: 30 AM - 11: 00 AM.
ActiGait implantable drop foot stimulator in multiple sclerosis: a new indication.

Pages